US EditionNew stem cell therapy for blood cancer patients - Fondazione Gianni Benzi Onlus
Summary by benzifoundation.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
New stem cell therapy for blood cancer patients - Fondazione Gianni Benzi Onlus
The European Medicines Agency (EMA) has recommended the conditional approval of Zemcelpro®, a promising new stem cell-based Advanced Therapy Medicinal Product (ATMP) designed to treat adults with haematological malignancies, including leukaemia, lymphoma, myeloma, and myelodysplastic syndrome, who lack a suitable stem cell donor for transplantation. Traditionally, stem cells for transplant are taken from a matched sibling or unrelated donor. Whe…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
